Minerva Surgical today claimed a win in its patent infringement war with Hologic (NSDQ:HOLX) over endometrial ablation technology, after a federal appeals court upheld a ruling that invalidates one of the Hologic patents in question. The convoluted battle involves the NovaSure device Hologic acquired with the 2007 buyout of Cytyc (which had acquired NovaSure developer Novacept […]
UPDATED May 6, 2019, with comment from Minerva. A Delaware federal judge this week denied Minerva Surgical‘s bid for a new trial in its $5 million patent infringement loss to Hologic (NSDQ:HOLX), despite an appeals court ruling last month that invalidated one of the patents at issue. Hologic’s NovaSure ablation device, acquired with the 2007 buyout […]
The U.S. Court of Appeals for the Federal Circuit today ruled against Hologic (NSDQ:HOLX) in a patent spat with Minerva Surgical, upholding a ruling from the U.S. Patent Trial and Appeal Board that claims on a patent Hologic owns, related to detecting perforations in body cavities during ablation, are unpatentable as obvious. In the case, Minerva […]
Minerva Surgical has raised $9.2 million from 17 investors as part of a $10 million offering, according to a document filed with the SEC this week. The Redwood City, CA.-based company makes the Minerva endometrial ablation system – a treatment designed to help women manage heavy menstrual bleeding. Heaving bleeding, which occurs in women between […]
A federal court jury last week awarded Hologic (NSDQ:HOLX) nearly $5 million in damages in a patent infringement lawsuit brought over their respective endometriosis devices. Hologic’s NovaSure ablation device, acquired with the 2007 buyout of Cytyc (which acquired NovaSure developer Novacept in 2004), competes with Minerva’s Aurora device. Hologic sued Minerva in November 2015 in the […]
Minerva Surgical is seeking the retraction of a study backed by rival Hologic (NSDQ:HOLX) comparing its NovaSure endometrial ablation system to Minerva’s competing device, alleging “material misleading statements” that violate ethics guidelines. Results from the 189-patient study, published in the International Journal of Women’s Health, found a higher one-year rate of amenorrhea and higher quality of life for women […]
Hologic (NSDQ:HOLX) yesterday released results from a study comparing its NovaSure endometrial ablation system to Minerva Surgical‘s endometrial ablation device, touting a higher one-year rate of amenorrhea and higher quality of life for women treated with the NovaSure, despite experiencing a higher rate of perioperative adverse events. Results from the trial were published in the International […]
Minerva Surgical reported a funding round worth $16.7 million and said it wants to raise $10 million more. Redwood City, Calif.-based Minerva, founded in 2008, is developing technologies for treatment of abnormal uterine bleeding. Its flagship device is the Aurora endometrial ablation system, which targets and eliminates the endometrial hyperplasia in a procedure that takes as little […]
September 24, 2014 by Brad Perriello
California women’s health company Minerva Surgical is just a stone’s throw from wrapping up an equity funding round slated to bring in $25.6 million.
Miramar Labs Inc. raised $35.8 million in a Series C funding round, leaving them just shy of their $36 million goal, according to an SEC filing.
The Sunnyvale, Calif.-based company’s claim to fame is miraDry, a laser-based treatment for excessive underarm sweat. The device uses microwave energy to cook sweat glands in two hour-long noninvasive doctor’s office visits.
The company plans to use the funds to begin marketing the device, according to Xconomy.